| abstract |
The present invention includes peptidomimetic compound compositions and methods of making peptidomimetic compounds. The peptidomimetic includes an oligo-ben/amide compound having at least three optionally substituted benzamidcs. The present invention also includes methods of making and using peptidomimetic compounds to modulate the activity of a peptide receptor for the treatment of one or more of hyperglycemia, insulin resistance, hyperinsulinemia, obesity, hyperlipidcmia, hyperlipoproteinemia or other symptoms that relate to the function of the targeted receptor. The peptidomimetic includes an oligo-benzamide compound having at least three optionally substituted benzamides. |